Save your place

Sign in to WhoBought

Please try again later.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) institutional ownership

Latest close $1.21 Jul 31, 2026
Market cap$52M 52-week range SectorHealthcare
Funds holding · Q1 2026
20
reported TELO position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
7 buyers · 13 sellers

Telomir Pharmaceuticals, Inc. Common Stock (TELO) price and institutional activity

Dates

Q1 2026

$0 bought by 7 investors
GeodeGoldman Sachs Group Inc +5 more
$0 sold by 13 investors
Millennium Management LLCVirtu Financial LLC +11 more
Bought Sold Totals per quarter; hover a bar for the names.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) institutional activity · 20

Investor Type Est. change Change Δ Own Date
Millennium Management LLC · Reduced
Change −38K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −38K Q1 2026
Geode · Added
Change +26K Date Q1 2026
Geode Added· Q1 2026 +26K Q1 2026
Virtu Financial LLC · Exited
Change −14K Δ Own −100.0% Date Q1 2026
Virtu Financial LLC Exited· Q1 2026 −14K −100.0% Q1 2026
Jane Street Group, LLC · Exited
Change −12K Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −12K −100.0% Q1 2026
Mariner, LLC · Exited
Change −12K Δ Own −100.0% Date Q1 2026
Mariner, LLC Exited· Q1 2026 −12K −100.0% Q1 2026
Goldman Sachs Group Inc · New
Change +10K Date Q1 2026
Goldman Sachs Group Inc New· Q1 2026 +10K Q1 2026
Two Sigma Securities, LLC · Exited
Change −10K Δ Own −100.0% Date Q1 2026
Two Sigma Securities, LLC Exited· Q1 2026 −10K −100.0% Q1 2026
Praetorian Wealth Management, Inc. · Added
Change +10K Date Q1 2026
Praetorian Wealth Management, Inc. Added· Q1 2026 +10K Q1 2026
UBS Group AG · Reduced
Change −5K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −5K Q1 2026
BlackRock · Added
Change +4K Date Q1 2026
BlackRock Added· Q1 2026 +4K Q1 2026
Xtx Topco Ltd · Reduced
Change −4K Date Q1 2026
Xtx Topco Ltd Reduced· Q1 2026 −4K Q1 2026
Ifp Advisors, Inc · Exited
Change −3K Δ Own −100.0% Date Q1 2026
Ifp Advisors, Inc Exited· Q1 2026 −3K −100.0% Q1 2026
Osaic Holdings, Inc. · Added
Change +2K Date Q1 2026
Osaic Holdings, Inc. Added· Q1 2026 +2K Q1 2026
World Investment Advisors · Added
Change +2K Date Q1 2026
World Investment Advisors Added· Q1 2026 +2K Q1 2026
Fortitude Family Office, LLC · Exited
Change −1K Δ Own −100.0% Date Q1 2026
Fortitude Family Office, LLC Exited· Q1 2026 −1K −100.0% Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 20

Famous investor activity in Telomir Pharmaceuticals, Inc. Common Stock (TELO)

Telomir Pharmaceuticals, Inc. Common Stock (TELO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Aminov Erez · Director 2 operations -4.0M
Owned 0 Trade date May 21, 2026 Filed date May 22, 2026
Aminov Erez Director 2 operations -4.0M 0 May 21, 2026 May 22, 2026
Aminov Erez · Director 2 operations 4.0M
Owned 2.0M Trade date May 21, 2026 Filed date May 22, 2026
Aminov Erez Director 2 operations 4.0M 2.0M May 21, 2026 May 22, 2026
Whalen Matthew Pratt · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K
Owned 0 Trade date May 21, 2026 Filed date May 22, 2026
Whalen Matthew Pratt Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K 0 May 21, 2026 May 22, 2026
Whalen Matthew Pratt · Director Grant (A) 25K
Owned 25K Trade date May 21, 2026 Filed date May 22, 2026
Whalen Matthew Pratt Director Grant (A) 25K 25K May 21, 2026 May 22, 2026
Macpherson Edward Clouston · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K
Owned 0 Trade date May 21, 2026 Filed date May 22, 2026
Macpherson Edward Clouston Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K 0 May 21, 2026 May 22, 2026
Macpherson Edward Clouston · Director Grant (A) 25K
Owned 25K Trade date May 21, 2026 Filed date May 22, 2026
Macpherson Edward Clouston Director Grant (A) 25K 25K May 21, 2026 May 22, 2026
Del Giudice Matthew Paul · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K
Owned 0 Trade date May 21, 2026 Filed date May 22, 2026
Del Giudice Matthew Paul Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -25K 0 May 21, 2026 May 22, 2026
Del Giudice Matthew Paul · Director Grant (A) 25K
Owned 25K Trade date May 21, 2026 Filed date May 22, 2026
Del Giudice Matthew Paul Director Grant (A) 25K 25K May 21, 2026 May 22, 2026
Aminov Erez · Director Other Form 4 events $10M
Price $1.37 Qty 7.3M Owned 7.3M Trade date Apr 22, 2026 Filed date Apr 24, 2026
Aminov Erez Director Other Form 4 events $1.37 7.3M $10M 7.3M Apr 22, 2026 Apr 24, 2026
Whalen Matthew Pratt · Director Grant (A) 50K
Owned 50K Trade date Apr 16, 2026 Filed date Jul 27, 2026
Whalen Matthew Pratt Director Grant (A) 50K 50K Apr 16, 2026 Jul 27, 2026
Macpherson Edward Clouston · Director Grant (A) 50K
Owned 50K Trade date Apr 16, 2026 Filed date Jul 27, 2026
Macpherson Edward Clouston Director Grant (A) 50K 50K Apr 16, 2026 Jul 27, 2026
Del Giudice Matthew Paul · Director Grant (A) 50K
Owned 50K Trade date Apr 16, 2026 Filed date Jul 27, 2026
Del Giudice Matthew Paul Director Grant (A) 50K 50K Apr 16, 2026 Jul 27, 2026
Aminov Erez · Director, Officer 2 operations 2.4M
Owned 400K Trade date May 28, 2025 Filed date May 30, 2025
Aminov Erez Director, Officer 2 operations 2.4M 400K May 28, 2025 May 30, 2025
Bay Shore Trust · 10% Owner Gift (G) -100K
Owned 2.3M Trade date Nov 21, 2024 Filed date Nov 25, 2024
Bay Shore Trust 10% Owner Gift (G) -100K 2.3M Nov 21, 2024 Nov 25, 2024
Yanez Michelle · Officer Grant (A) 200K
Owned 200K Trade date Aug 27, 2024 Filed date Sep 4, 2024
Yanez Michelle Officer Grant (A) 200K 200K Aug 27, 2024 Sep 4, 2024
15 of 22
15 of 22 Sign in to continue to older insider transactions.

Telomir Pharmaceuticals, Inc. Common Stock (TELO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
John Paul Dejoria, AS Trustee of the John Paul Dejoria Family Trust, and In His Individual Capacity 3.2M
% of shares outstanding 9.4% Filing date Feb 12, 2026
John Paul Dejoria, AS Trustee of the John Paul Dejoria Family Trust, and In His Individual Capacity 3.2M 9.4% Feb 12, 2026
1 of 1

Telomir Pharmaceuticals, Inc. Common Stock (TELO) ownership FAQ

Who owns TELO?

20 reporting institutions disclosed TELO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.